Cargando…
An open-label phase I dose-finding study of APR-246 in hematological malignancies
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5141349/ https://www.ncbi.nlm.nih.gov/pubmed/27421096 http://dx.doi.org/10.1038/bcj.2016.60 |
| _version_ | 1782472595166199808 |
|---|---|
| author | Deneberg, S Cherif, H Lazarevic, V Andersson, P-O von Euler, M Juliusson, G Lehmann, S |
| author_facet | Deneberg, S Cherif, H Lazarevic, V Andersson, P-O von Euler, M Juliusson, G Lehmann, S |
| author_sort | Deneberg, S |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5141349 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-51413492016-12-22 An open-label phase I dose-finding study of APR-246 in hematological malignancies Deneberg, S Cherif, H Lazarevic, V Andersson, P-O von Euler, M Juliusson, G Lehmann, S Blood Cancer J Letter to the Editor Nature Publishing Group 2016-07 2016-07-15 /pmc/articles/PMC5141349/ /pubmed/27421096 http://dx.doi.org/10.1038/bcj.2016.60 Text en Copyright © 2016 The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
| spellingShingle | Letter to the Editor Deneberg, S Cherif, H Lazarevic, V Andersson, P-O von Euler, M Juliusson, G Lehmann, S An open-label phase I dose-finding study of APR-246 in hematological malignancies |
| title | An open-label phase I dose-finding study of APR-246 in hematological malignancies |
| title_full | An open-label phase I dose-finding study of APR-246 in hematological malignancies |
| title_fullStr | An open-label phase I dose-finding study of APR-246 in hematological malignancies |
| title_full_unstemmed | An open-label phase I dose-finding study of APR-246 in hematological malignancies |
| title_short | An open-label phase I dose-finding study of APR-246 in hematological malignancies |
| title_sort | open-label phase i dose-finding study of apr-246 in hematological malignancies |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5141349/ https://www.ncbi.nlm.nih.gov/pubmed/27421096 http://dx.doi.org/10.1038/bcj.2016.60 |
| work_keys_str_mv | AT denebergs anopenlabelphaseidosefindingstudyofapr246inhematologicalmalignancies AT cherifh anopenlabelphaseidosefindingstudyofapr246inhematologicalmalignancies AT lazarevicv anopenlabelphaseidosefindingstudyofapr246inhematologicalmalignancies AT anderssonpo anopenlabelphaseidosefindingstudyofapr246inhematologicalmalignancies AT voneulerm anopenlabelphaseidosefindingstudyofapr246inhematologicalmalignancies AT juliussong anopenlabelphaseidosefindingstudyofapr246inhematologicalmalignancies AT lehmanns anopenlabelphaseidosefindingstudyofapr246inhematologicalmalignancies AT denebergs openlabelphaseidosefindingstudyofapr246inhematologicalmalignancies AT cherifh openlabelphaseidosefindingstudyofapr246inhematologicalmalignancies AT lazarevicv openlabelphaseidosefindingstudyofapr246inhematologicalmalignancies AT anderssonpo openlabelphaseidosefindingstudyofapr246inhematologicalmalignancies AT voneulerm openlabelphaseidosefindingstudyofapr246inhematologicalmalignancies AT juliussong openlabelphaseidosefindingstudyofapr246inhematologicalmalignancies AT lehmanns openlabelphaseidosefindingstudyofapr246inhematologicalmalignancies |